$HYH (Halyard Health, Inc.)

$HYH {{ '2015-12-11T10:53:07+0000' | timeago}} • Announcement

$HYH said it received federal contract to research and develop high-speed machine to produce respirators for use during pandemics. BARDA will fund research by Halyard to develop a one-of-a-kind, high-speed machine to manufacture N95 Filtering Facepiece Respirators (FFRs) that can be used during a pandemic. $HYH will begin work on project in Jan.

$ABT {{ '2017-10-20T18:04:31+0000' | timeago}} • Webcast

$ABT stated that regarding Alere, the company expects it to contribute around $475MM to its reported sales in FY17 and forecasts a neutral impact on adjusted EPS for the year. For FY17, $ABT continues to forecast comparable operational sales growth in the mid-single digits.

$ABT {{ '2017-10-20T17:56:19+0000' | timeago}} • Webcast

$ABT continues to anticipate CE Mark for its Alinity molecular diagnostic systems in the coming months and expect to begin the launch of the Alinity instruments in the US in 2018. In nutrition business outside China, the company expects to see soft market conditions across few international markets.

$FTI {{ '2017-10-19T09:45:17+0000' | timeago}} • Announcement

$FTI signed an agreement with Plexus Holding plc to acquire Plexus's Wellhead exploration equipment and services business for jack up applications. The acquired business will be integrated into the TechnipFMC Surface Technologies segment. Financial details of the transaction were not disclosed.

$ABT {{ '2017-10-18T18:04:16+0000' | timeago}} • Announcement

$ABT narrowed its FY17 EPS outlook range, which continues to reflect double-digit growth. The company now expects GAAP EPS to be $0.97-0.99 for FY17, while adjusted diluted EPS is now expected in the range of $2.48-2.50, which represents an increase at the mid-point of the guidance range. For 4Q17, $ABT expects EPS to be $0.28-$0.30.

$ABT {{ '2017-10-18T17:33:26+0000' | timeago}} • Announcement

$ABT swung to profit in 3Q17 on higher device sales and benefits from St. Jude Medical acquisition. Strength in medical devices business helped the company post a profit of $603MM or $0.32 per share from a loss of $329MM or $0.24 per share a year ago. Net sales jumped 28.8% to $6.8Bil, with adjusted EPS climbing 12% to $0.66 per share.

$ABT {{ '2017-10-18T13:13:48+0000' | timeago}} • Infographic

$ABT Abbott Laboratories Earnings AlphaGraphic: Q3 2017 Highlights

$BAX {{ '2017-10-12T20:41:03+0000' | timeago}} • Announcement

$BAX provided updates regarding recovery efforts following the impact of Hurricane Maria on its Puerto Rico operations. While $BAX now anticipates a reduction in revenue for 4Q17 as a result of the storm, the company expects to mitigate the related earnings impact through positive performance in other areas of the business.

$BSX {{ '2017-10-04T14:52:08+0000' | timeago}} • Announcement

$BSX appointed Desiree Ralls-Morrison as SVP, general counsel and corporate secretary. Ralls-Morrison will join $BSX on Nov. 30, 2017, as a member of the executive committee. Ralls-Morrison will succeed Timothy Pratt, EVP, general counsel and corporate secretary, who announced his intention to retire from the company in April 2017.

$BAX {{ '2017-10-03T14:37:28+0000' | timeago}} • Announcement

$BAX announced enrollment of first patients in two new clinical trials for a unique expanded hemodialysis (HDx) therapy enabled by Theranova. Baxter’s HDx therapy enabled by Theranova was designed to remove large molecular weight toxins that have been associated with inflammation and cardiovascular health for end-stage renal disease patients.

$VVV {{ '2017-10-02T21:27:08+0000' | timeago}} • Announcement

$VVV has completed the acquisition of 56 Valvoline Instant Oil ChangeSM (VIOC) franchise service centers from Henley Bluewater LLC. Following the acquisition, the company has a network of 439 company-owned locations.

$BSX {{ '2017-10-02T20:46:11+0000' | timeago}} • Announcement

$BSX agreed to acquire privately-held Apama Medical Inc. for $175MM in cash upfront and a maximum of $125MM in contingent payments over 2018-2020 based on achievements of clinical and regulatory milestones. Closure is expected in 4Q17.  The deal is expected to be immaterial to adjusted EPS for 2017 and 2018 but more dilutive on a GAAP basis.

$TFX {{ '2017-10-02T20:23:51+0000' | timeago}} • Announcement

$TFX completed the acquisition of NeoTract, Inc. for $1.1Bil. Under the terms of the agreement, $TFX acquired NeoTract for an upfront cash payment of $725MM at closing, and has agreed to pay up to an additional $375MM upon the achievement of certain commercial milestones related to sales through the end of 2020.

$FTI {{ '2017-10-02T17:38:12+0000' | timeago}} • Announcement

Levi & Korsinsky LLP reminded shareholders of $FTI of a class action lawsuit and a lead plaintiff deadline of Oct. 2, 2017. The lawsuit was filed in the Southern District Court of Texas, Houston Division on behalf of persons or entities who purchased or otherwise acquired securities of $FTI between April 27, 2017 and July 24, 2017.

$SGMO {{ '2017-10-02T16:06:18+0000' | timeago}} • Announcement

$SGMO and $BIVV said the FDA has accepted the Investigational New Drug (IND) application for ST-400, a gene-edited cell therapy candidate for people with transfusion-dependent beta-thalassemia. $SGMO expects to open several clinical sites across the United States and begin enrolling patients in 1H18.

$SGMO {{ '2017-10-02T16:05:15+0000' | timeago}} • Announcement

$SGMO and $BIVV said the FDA has accepted the Investigational New Drug (IND) application for ST-400, a gene-edited cell therapy candidate for people with transfusion-dependent beta-thalassemia. This is as part of exclusive worldwide collaboration to develop and commercialize gene-edited cell therapies for beta-thalassemia and sickle cell disease.

$ABT {{ '2017-10-02T12:48:41+0000' | timeago}} • Announcement

$ABT extended tender offer to purchase for cash all outstanding shares of Series B Convertible Perpetual Preferred Stock of Alere Inc. at a price of $402 per share. The Offer is being extended to allow additional time for the consummation of the Merger. The offer will now expire on Oct. 3, 2017.

$BDX {{ '2017-09-29T15:36:16+0000' | timeago}} • Announcement

Medical technology company $BDX has named Timothy M Ring and David F Melcher to its BoD, following completion the company’s acquisition of CR Bard Inc. Ring has been serving as Chairman and CEO of Bard since August 2003. Melcher, also a director of Bard, is President and CEO of the Aerospace Industries Association.

$ABT {{ '2017-09-29T14:25:12+0000' | timeago}} • Announcement

$ABT said it plans to close the acquisition of $ALR on October 3, 2017.  With the addition of $ALR, $ABT will have approx. $7Bil in diagnostics sales worldwide, including approx. $2.5Bil on point of care testing.

$VVV {{ '2017-09-29T11:54:15+0000' | timeago}} • Announcement

Supplier of premium branded lubricants and automotive services $VVV said that William Wulfsohn, who served as the company's founding chairman during its initial year as a public company, will step down from his position as Chairman of the Board as of Sept. 30, 2017.

$FTI {{ '2017-09-28T13:54:48+0000' | timeago}} • Announcement

$FTI has been awarded an Engineering, Procurement, Construction and Installation contract by Statoil. It covers the execution of the subsea pipeline connection for the new production platform in Peregrino Phase II Project, located in Campos Basin, offshore Brazil.

Recent Transcripts

ABT (Abbott Laboratories)
Wednesday, October 18 2017 - 1:00pm
INFO (IHS Markit Ltd.)
Tuesday, September 26 2017 - 12:00pm
AOBC (American Outdoor Brands Corporation)
Thursday, September 7 2017 - 9:00pm
HOME (At Home Group Inc.)
Tuesday, September 5 2017 - 8:30pm
BDX (Becton, Dickinson and Company)
Thursday, August 3 2017 - 12:00pm
TFX (Teleflex Incorporated)
Thursday, August 3 2017 - 12:00pm
BIVV (Bioverativ Inc.)
Thursday, August 3 2017 - 12:00pm
VVV (Valvoline Inc.)
Wednesday, August 2 2017 - 3:00pm
HYH (Halyard Health, Inc.)
Wednesday, August 2 2017 - 1:00pm
PCRX (Pacira Pharmaceuticals, Inc.)
Wednesday, August 2 2017 - 12:30pm
CAH (Cardinal Health, Inc.)
Wednesday, August 2 2017 - 12:30pm
ITGR (Integer Holdings Corporation)
Thursday, July 27 2017 - 9:00pm
SYK (Stryker Corporation)
Thursday, July 27 2017 - 8:30pm
FTI (TechnipFMC plc)
Thursday, July 27 2017 - 12:00pm
BSX (Boston Scientific Corporation)
Thursday, July 27 2017 - 12:00pm
BAX (Baxter International Inc.)
Wednesday, July 26 2017 - 12:30pm
AMD (Advanced Micro Devices, Inc.)
Tuesday, July 25 2017 - 9:00pm
ABT (Abbott Laboratories)
Thursday, July 20 2017 - 1:00pm
AOBC (American Outdoor Brands Corporation)
Thursday, June 29 2017 - 9:00pm
HOME (At Home Group Inc.)
Wednesday, June 7 2017 - 12:30pm

AlphaGraphics you may like